Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jun 14;18(6):e0286762. doi: 10.1371/journal.pone.0286762

Reliability and validity of the Forgotten Joint Score-12 for total ankle replacement and ankle arthrodesis

Koji Noguchi 1,2, Satoshi Yamaguchi 3,4,*, Atsushi Teramoto 5, Kentaro Amaha 6, Noriyuki Kanzaki 7, Hirofumi Tanaka 8, Tetsuro Yasui 9, Yosuke Inaba 10
Editor: Fatih Özden11
PMCID: PMC10266669  PMID: 37315039

Abstract

Objectives

This study evaluated the reliability and validity of the Forgotten Joint Score-12 (FJS-12)—a measure of patients’ ability to forget their joints in daily life—in patients who underwent total ankle replacement (TAR) or ankle arthrodesis (AA).

Methods

Patients who underwent TAR or AA were recruited from seven hospitals. The patients completed the Japanese version of FJS-12 twice, at an interval of two weeks, at a minimum of one year postoperatively. Additionally, they answered the Self-Administered Foot Evaluation Questionnaire and EuroQoL 5-Dimension 5-Level as comparators. The construct validity, internal consistency, test-retest reliability, measurement error, and floor and ceiling effects were evaluated.

Results

A total of 115 patients (median age, 72 years), comprising 50 and 65 patients in the TAR and AA groups respectively, were evaluated. The mean FJS-12 scores were 65 and 58 for the TAR and AA groups, respectively, with no significant difference between groups (P = 0.20). Correlations between the FJS-12 and Self-Administered Foot Evaluation Questionnaire subscale scores were good to moderate. The correlation coefficient ranged from 0.39 to 0.71 and 0.55 to 0.79 in the TAR and AA groups, respectively. The correlation between the FJS-12 and EuroQoL 5-Dimension 5-Level scores was poor in both groups. The internal consistency was adequate, with Cronbach’s α greater than 0.9 in both groups. The intraclass correlation coefficients of test-retest reliability was 0.77 and 0.98 in the TAR and AA groups, respectively. The 95% minimal detectable change values were 18.0 and 7.2 points in the TAR and AA groups, respectively. No floor or ceiling effect was observed in either group.

Conclusions

The Japanese version of FJS-12 is a valid and reliable questionnaire for measuring joint awareness in patients with TAR or AA. The FJS-12 can be a useful tool for the postoperative assessment of patients with end-stage ankle arthritis.

Introduction

Total ankle replacement (TAR) and ankle arthrodesis (AA) are two common surgical procedures used to treat end-stage ankle arthritis. Advancements in operative techniques and aging population has increased the number of these operations worldwide [1, 2].

The significance of patient-reported outcome measures (PROMs) is increasingly recognized for the postoperative evaluation of TAR and AA. Various PROMs have been used to measure foot and ankle outcomes [3]. However, no single outcome accurately depicts the difficulties that patients with end-stage ankle arthritis [4]. Additionally, some foot and ankle instruments have insufficient psychometric properties such as floor and ceiling effects [5] and limited validity [6]. Consequently, there is no consensus on the most appropriate instrument for this patient population [7]. Furthermore, several existing PROMs are lengthy, which burdens patients and may lead to loss of follow-up [8]. A simple and sufficiently validated PROM is therefore required.

The Forgotten Joint Score-12 (FJS-12) is a new PROM based on the assumption that the ultimate goal of a joint operation is to forget the joint [9]. The FJS-12 consists of 12 questions on joint awareness of daily activities, such as walking, climbing stairs, and doing household chores. It was originally introduced for postoperative assessment of total knee or hip arthroplasty, and its validity and reliability have been documented [10]. This measurement had no or low floor and ceiling effects, indicating that it could distinguish between patients with good and excellent outcomes [10]. Consequently, FJS-12 has been translated into different languages and is increasingly used worldwide. The Japanese version was created using a cross-cultural translation and adaptation process (S1 File) [11]. Its reliability and validity have been tested in patients who have undergone total knee and hip arthroplasty [11].

The FJS-12 has recently been used in other groups of patients, such as those who underwent unicompartmental knee arthroplasty, high tibial osteotomy, and patellar dislocation [12, 13]. The questions in the FJS-12 can be applied to the assessment of patients with foot and ankle diseases because the questions include items on symptoms during locomotive activities. Although the usefulness of FJS-12 has not been proven, it was used in a study to evaluate patients with hallux rigidus [14]. To date, the psychometric properties of the FJS-12, either the original English or Japanese version, have not been tested in patients who have undergone TAR and AA. Therefore, this study aimed to evaluate the reliability and validity of the Japanese version of the FJS-12 for the TAR and AA. We hypothesized that the Japanese version of the FJS-12 would be valid and reliable to measure joint awareness after TAR or AA.

Materials and methods

Patient recruitment

Consecutive patients were recruited from the foot and ankle outpatient clinics of seven hospitals between February and November 2021. Patients who underwent TAR or AA and had a minimum follow-up duration of one year were included in this study. Patients who were unable to answer the questionnaires owing to cognitive impairment or mental disorders, those who were unable to walk independently at the time of the questionnaire survey, or those with a history of neurological disorders, such as diabetic neuropathy, were excluded. Patients who did not provide consent to participate were excluded.

The research ethics committees of the institutions (Kurume University School of Medicine, approval number, 20239; Graduate School of Medicine, Chiba University, approval number, 4052; Hyakutake Orthopedic Surgery and Sports Clinic, approval number, 2102; St. Luke’s International Hospital, approval number, 21-R007; Sapporo Medical University School of Medicine, approval number, 332–9; Kobe University Graduate School of Medicine, approval number, B210057; Teikyo University Mizonokuchi Hospital, approval number, TUIC-COI21-0150) approved this study, and all patients provided written informed consent.

Patients’ demographics

The patients’ demographics, including the type of operative procedure (TAR or AA), age, sex, diagnosis, postoperative follow-up duration, laterality of the operation (unilateral or bilateral), and primary/revision surgery, were obtained from their medical records. The implant type was recorded for patients who underwent TAR. Regarding patients who underwent AA, details of the operative procedure (arthroscopic or open) were surveyed.

Questionnaires

The patients answered the questionnaires in an outpatient setting for more than one year postoperatively. In the first round of evaluation, they completed the FJS-12 [9], Self-Administered Foot Evaluation Questionnaire (SAFE-Q) [15], and EuroQoL 5-Dimension 5-Level (EQ-5D-5L) [16]. In the second round of evaluation (two weeks after the first evaluation), the patients were asked to complete the FJS-12 and global rating scale. Patients who underwent bilateral ankle surgery answered a questionnaire based on the side that was first operated on.

The FJS-12 consists of 12 questions on the respondent’s joint awareness related to activities of daily living [9]. Patients assessed each item on a 5-point Likert scale: never (0), almost never (1), seldom (2), sometimes (3), and mostly (4). The item scores were summed and converted into a scale ranging from 0 to 100, with a higher score indicating a patient’s greater ability to forget the affected joint. Patients with more than four missing answers were excluded from the analysis [9].

The SAFE-Q is a 34-item questionnaire that has proven to be a good tool for assessing the quality of life of patients with foot and ankle diseases [15]. The SAFE-Q has been widely used for evaluating patients with end-stage ankle arthritis [17, 18]. The outcome consists of five subscales: pain and pain-related, physical functioning and daily living, social functioning, shoe-related, and general health and well-being. Responses to each question were rated from 0 to 4 and then converted to subscale scores ranging from 0 to 100, with a higher score indicating a better ankle condition.

The EQ-5D-5L is a self-reported measure used to evaluate general health status [16]. It consists of the descriptive system and EQ visual analog scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The answers to each dimension were in five levels, ranging from no problems (1) to extreme problems (5). The responses to the five dimensions were converted into a single summary number called an index value. The possible score ranged from -0.025 to 1, and a value of 1 indicated full health. The EQ VAS records the patient’s self-rated health on a vertical scale, where the end-points are labeled “the best health you can imagine (100)” and “the worst health you can imagine (0).”

The global rating scale was used to examine whether the global condition of the operated ankle changed between the first and second evaluations. The answers were rated from (1) completely recovered to (7) vastly worsened [19]. Based on a previous report, patients rated between 3 and 5 in the second evaluation were considered stable and were included in the analysis [19]. Patients rated 1, 2, 6, or 7 were excluded because their condition changed between evaluations [19].

Statistics

The patients were grouped into two: those who had undergone TAR (TAR group) and AA (AA group). Patients’ demographics and questionnaire results were compared between the TAR and AA groups using the Wilcoxon signed-rank tests, Student t-test, and Fisher’s exact test as appropriate.

Distribution of FJS-12 scores

The normality of the FJS-12 scores was examined using the Shapiro–Wilk test. The percentage of missing responses was then calculated.

Construct validity and hypothesis testing

Regarding construct validity, correlations between the FJS-12 and subscale scores of the SAFE-Q and EQ-5D were assessed using Spearman’s correlation coefficients. Correlation coefficients higher than 0.7 were considered good, 0.3 to 0.7 moderate, and lower than 0.3 poor [20]. We hypothesized that the correlation between the FJS-12 and SAFE-Q subscales would be good to moderate. We also hypothesized that the correlation between the FJS-12 and EQ-5D-5L would be moderate to poor because the EQ-5D score is affected by factors such as comorbidities that are unrelated to the ankle joint [21]. To assess known-group validity, the FJS-12 scores were compared between the TAR and AA groups using the Student t-test. We hypothesized that the scores were similar between the groups. If at least 75% of the hypotheses (12 out of 15 hypotheses) were confirmed, the construct validity was considered adequate [22].

Internal consistency

Internal consistency was assessed using Cronbach’s α, which was considered adequate if the value was between 0.70 and 0.95 [22].

Factor analysis

Principal component analysis with Varimax rotation was performed to assess the dimensionality of the FJS-12 using the overall data of the TAR and AA groups.

Test-retest reliability

The test-retest reliability was evaluated by calculating the intraclass correlation coefficient (ICC)agreement for a two-way random-effects model, single measurement. The ICC was considered adequate if the value was higher than 0.70 [22].

Measurement error

The standard error of measurement (SEM) and 95% minimal detectable change (MDC95) were used to express measurement error. SEM was calculated as follows: SEM = SD × √ (1 − ICC), where SD is the standard deviation of the difference between the two scores. MDC95 was calculated as follows: MDC95 = 1.96 ×√2 × SEM [22].

Floor and ceiling effects

Floor and ceiling effects for the FJS-12 were considered present if more than 15% of the patients had the lowest (0) or highest (100) scores [22].

Sample size

The sample size was determined based on the recommendation of the COnsensus-based Standards for the selection of health Measurement INstruments, in which 50 or more patients were adequate in assessing the measurement property of a PROM [23]. Assuming that 20% of patients were excluded from the analysis, we determined a sample size of 63 patients for each group (50/0.8 = 62.5). Statistical analyses were performed using commercially available statistical software (JMP Pro 15.1.0, SAS Institute, Cary, NC, USA and Bell Curve for Excel, Social Survey Research Information, Shinjuku, Tokyo, Japan). Statistical significance was set at a P-value less than 0.05.

Results

Patients’ demographics

Among the 142 patients screened for eligibility, 27 were excluded. Data from the remaining 115 patients, 50 in the TAR group (Fig 1A) and 65 in the AA group (Fig 1B), were analyzed. There were 87 women and 28 men, with a median age of 72 (25th and 75th percentiles: 67 and 79) years (Table 1).

Fig 1. Patient flow diagram.

Fig 1

(A) patient after total ankle replacement, (B) patients after ankle arthrodesis.

Table 1. Patient demographics and outcome scores.

TAR group (n = 50) AA group (n = 65) P
Age (years) 78 (72, 81) 70 (62, 73) < 0.001a
Sex (Women, n [%]) 40 (80) 47 (72) 0.39b
Diagnosis (n [%]) Idiopathic OA 23 (46) 24 (37) 0.008b
Post-traumatic OA 8 (16) 13 (20)
Post-sprain OA 7 (14) 24 (37)
Rheumatoid arthritis 9 (18) 3 (5)
Others 3 (6) 1 (2)
Postoperative follow-up (months) 29 (17, 56) 34 (19, 51) 0.48a
Operative procedure (n [%]) TNK ankle 13 (26) n.a.
TNK ankle + total talar prosthesis 17 (34) n.a.
FINE Ankle 1 (2) n.a.
TM Ankle 19 (38) n.a.
Arthroscopic arthrodesis n.a. 60 (92)
Open arthrodesis n.a. 5 (8)
Bilateral operation (n [%]) 2 (4) 3 (5) 1.00b
Revision operation (n [%]) 1 (2) 3 (5) 0.63b
Interval between 1st and 2nd FJS (days) 14 (14, 14) 14 (14, 15) 0.09a
FJS-12 (mean ± standard deviation) 64 ± 20 58 ± 26 0.20c
SAFE-Q Pain 87 (77, 100) 94 (79, 100) 0.15a
Physical Functioning 76 (68, 87) 77 (64, 89) 0.79a
Social Functioning 88 (74, 100) 100 (75, 100) 0.06a
Shoe-Related 83 (67, 100) 83 (67, 96) 0.27a
General Health 93 (80, 100) 90 (80, 100) 0.94a
EQ-5D-5L Descriptive system index value 0.86 (0.74, 0.89) 0.89 (0.78, 1) 0.21a
EQ VAS 80 (74, 90) 80 (70, 90) 0.63a

Values indicate the median (25th and 75th percentiles) unless indicated otherwise. TAR, total ankle replacement; AA, ankle arthrodesis; FJS, Forgotten Joint Score; SAFE-Q, Self-Administered Foot Evaluation Questionnaire; EQ-5D-5L, EuroQoL 5-dimension 5-level; VAS, visual analogue scale; OA, osteoarthritis; TNK Ankle (Kyocera, Fushimi-cho, Kyoto, Japan); FINE Ankle (Teijin Nakashima Medical, Higashi-ku, Okayama, Japan); TM Ankle (Zimmer, Biomet, Warsaw, IN, USA); n.a., not applicable; n; number of patients.

bFisher’s exact test.

cStudent t-test.

Distribution of FJS-12 scores

The FJS-12 scores were normally distributed in both TAR (P = 0.48, Fig 2A) and AA groups (P = 0.14, Fig 2B). The overall proportion of missing responses was 28/600 (5%) and 12/780 (2%) in the TAR and AA groups, respectively. Question 12, an item on sports activities, had the highest percentage of missing responses with 20/50 (40%) and 7/65 (11%) missing responses in the TAR and AA groups, respectively.

Fig 2. Distribution of FJS-12 scores.

Fig 2

(A) patient after total ankle replacement, (B) patients after ankle arthrodesis.

Construct validity

In the TAR group, the correlations between the FJS-12 and SAFE-Q subscale scores were good to moderate, with the correlation coefficient ranging from 0.39 to 0.71 (Table 2). There was a moderate correlation between the FJS-12 and EQ-5D-5L descriptive system index values, but no correlation between the FJS-12 and EQ VAS scores (Table 2). In the AA group, the correlation coefficient between the FJS-12 and SAFE-Q subscales ranged from 0.55 to 0.79 (Table 2). The correlations between the FJS-12 and EQ-5D-5L were also moderate to good. There was no significant difference in the FJS-12 score between the two groups, although the score was 7 points higher in the TAR group than in the AA group (P = 0.20, Table 1). Among the 15 hypotheses, 14 corresponded with our hypotheses.

Table 2. Correlations of the FJS-12 with the SAFE-Q and EQ-5D-5L.

TAR group (n = 50) AA group (n = 65)
ρ P ρ P
SAFE-Q Pain 0.71 < 0.001 0.62 < 0.001
Physical functioning 0.61 < 0.001 0.79 < 0.001
Social functioning 0.39 0.006 0.71 < 0.001
Shoe-related 0.61 < 0.001 0.55 < 0.001
General health 0.59 < 0.001 0.68 < 0.001
EQ-5D-5L Descriptive system index value 0.34 0.01 0.70 < 0.001
EQ VAS 0.05 0.73 0.51 < 0.001

TAR, total ankle replacement; AA, ankle arthrodesis; FJS, Forgotten Joint Score; SAFE-Q, Self-Administered Foot Evaluation Questionnaire; EQ-5D-5L, EuroQoL 5-dimension 5-level; VAS, visual analog scale; ρ, Spearman correlation coefficient; n; number of patients.

Internal consistency

A high level of internal consistency was found, with Cronbach’s α of 0.92 and 0.94 in the TAR and AA groups, respectively.

Factor analysis

The first factor explained 58.9% of the variance, with an eigenvalue of 7.06 (Fig 3). The first factor mainly represented difficulties during activities, such as items 3, 6–8, 11, and 12 (Table 3). The second factor explained 9.9% of the variance, with an eigenvalue of 1.19. This factor mainly represented difficulties at rest, such as items 1, 2, 4, and 5.

Fig 3. Scree plot of FJS-12.

Fig 3

Table 3. Factor loading of the FJS-12.

FJS 12 items Factor 1 Factor 2
1 0.249 0.680
2 0.237 0.872
3 0.599 0.521
4 0.418 0.604
5 0.385 0.622
6 0.736 0.212
7 0.830 0.295
8 0.735 0.294
9 0.733 0.348
10 0.665 0.329
11 0.720 0.457
12 0.662 0.350

Bold numbers indicate the factor loading > 0.4.

Test-retest reliability and measurement error

In the TAR group, the ICC of the FJS-12 score was 0.77 (95% confidence interval [CI], 0.63 to 0.86), showing adequate reliability; the SEM was 6.5, and the MDC95 was 18.0 (S2 File). The reliability in the AA group was also sufficient, with an ICC of 0.93 (95% CI, 0.89 to 0.96); the SEM value was 2.6, and the MDC95 value was 7.2 (S2 File).

Floor and ceiling effects

None of the patients in the TAR group had a score of 0 and one patient (2%) had a score of 100. In the AA group, three (5%) patients scored 0, and two (3%) patients scored 100 (Fig 2). Therefore, there was no floor or ceiling effect in either group.

Discussion

This study showed that FJS-12 scores were moderately to highly correlated with SAFE-Q scores after operative treatment for end-stage ankle arthritis. The test-retest reliability and measurement errors were acceptable. No floor or ceiling effects were observed.

Our data showed good-to-moderate correlations between the FJS-12 and SAFE-Q subscale scores in both the TAR and AA groups. The correlation coefficients between FJS-12 and EQ-5D-5L scores were lower than those between FJS-12 and SAFE-Q scores. A good correlation between the FJS-12 and SAFE-Q scores is reasonable because they include similar questions, such as items about walking for a long time, walking on uneven ground, and climbing stairs [9, 15]. The FJS-12 has been shown to have good construct validity in evaluating patients after total knee and hip arthroplasty, high tibial osteotomy, anterior cruciate ligament reconstruction, or hip arthroscopy [10, 2426]. The FJS-12 may be used as a simple and valid instrument for assessing TAR and AA.

There was no significant difference in the FJS-12 score between the TAR and AA groups, although the score was slightly higher in the TAR group than in the AA group. This study, therefore, confirmed the construct validity of the questionnaire. Our results were consistent with a recent systematic review that found equality in PROMs after TAR and AA [27]. However, the patients in the TAR group were 8 years older than those in the AA group. Although not the main objective of this study, a comparison of TAA and AA requires further research.

In this study, the principal component analysis showed the two dimensions of the FJS-12, although the eigenvalue for the first factor was six times larger than that of the second factor (7.06 versus 1.09). In contrast, studies using patients after total knee arthroplasty and anterior cruciate reconstruction reported unidimensionality of the FJS-12 [24, 28]. The differences in the patient background and analysis methods are possible explanations for the discrepancy. Further studies are required to confirm the factor structure of the FJS-12 for patients after TAR and AA.

In this study, the test-retest reliability was adequate for patients who underwent AA. In patients who underwent TAR, the ICC was 0.77; however, it was higher than the minimum standard for reliability [22]. A recent systematic review found that the test-retest reliability of the FJS-12 was higher than 0.8 in patients who underwent total knee and hip arthroplasties [10]. A more recent study reported an ICC value of 0.76 after total joint arthroplasty [29]. Therefore, the FJS-12 was as reliable for patients with end-stage ankle arthritis after surgery as it was for those with other joint diseases.

This study showed that the MDC95 values for the Japanese FJS-12 were 18.0 and 7.2 points in the TAR and AA groups, respectively. The results for the MDC95 are comparable to those obtained for patients treated with total knee arthroplasty, which ranged from 13 to 24 points [30, 31]. Similarly, the MDC95 was between 14 and 21 points after total hip arthroplasty [30, 32]. However, the patients who underwent hip arthroscopy had a high MDC95 of 32 points [33]. The clinical explanation for this variability is that patients who underwent AA had stable levels of postoperative joint awareness, perhaps because of the loss of ankle mobility. Conversely, patients who underwent TAR and total knee arthroplasties experienced fluctuations in symptoms, which would reasonably be expected for reconstructed mobile joints.

The FJS-12 had no ceiling or floor effects in patients who underwent TAR or AA. This contrasts with the SAFE-Q, in which most subscales had ceiling effects. The results of this study suggest that a forgotten ankle is difficult to achieve, even after successful TAR and AA. Similar to the findings of our study, the FJS-12 had little or no ceiling effect in total knee and hip arthroplasties [10]. The results also indicate that the FJS-12 effectively detects small differences among well-functioning patients. The evaluation of these patients after TAR will become more important because operative techniques and implant designs have advanced over the past decade, leading to better outcomes. However, further research is warranted to determine whether small differences in the FJS-12 scores are clinically relevant.

This study has several limitations. First, the patients were relatively old, possibly owing to Japan’s aging population. Further studies with a wider age range are required. Second, the responsiveness of the FJS-12 score was not assessed owing to the cross-sectional nature of this study. Longitudinal studies are required to clarify whether FJS-12 can capture changes in patient status over time. Third, the content validity of the FJS-12 was not assessed in the population with ankle disease; consequently, the items contained in the questionnaire may not be comprehensive or relevant for this patient population. Fourth, the SAFE-Q was used to assess the ankle disease-specific outcomes. This is because other commonly used instruments, such as the European Foot and Ankle Society Score and Foot and Ankle Outcome Score [34, 35], do not have a Japanese version. However, the SAFE-Q has been widely used to evaluate patients treated with TAR and AA [17, 18]. Fifth, we used the Japanese version of the FJS-12 [11]. The validity and reliability of other language versions of the FJS-12 require confirmation in future studies. Finally, the number of patients was not based on the sample size calculation. However, we determined the sample size according to the recommendation of the widely accepted guidelines [23]. Furthermore, the post hoc statistical power analysis using the correlation between the FJS-12 and SAFE-Q scores showed the statistical power ranged from 0.80 to 0.99.

In conclusion, the Japanese version of the FJS-12 was a valid and reliable PROM that could differentiate between patients with excellent and good outcomes after the operative treatment of end-stage ankle arthritis. The FJS-12 can be a useful tool for the postoperative assessment of patients with end-stage ankle arthritis.

Supporting information

S1 File. Japanese version of FJS-12.

(DOCX)

S2 File. FJS scores.

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Pugely AJ, Lu X, Amendola A, Callaghan JJ, Martin CT, Cram P. Trends in the use of total ankle replacement and ankle arthrodesis in the United States Medicare population. Foot Ankle Int. 2014;35:207–215. doi: 10.1177/1071100713511606 [DOI] [PubMed] [Google Scholar]
  • 2.Milstrey A, Domnick C, Garcia P, Raschke MJ, Evers J, Ochman S. Trends in arthrodeses and total joint replacements in Foot and Ankle surgery in Germany during the past decade-Back to the fusion? Foot Ankle Surg. 2020;27:301–304. doi: 10.1016/j.fas.2020.05.008 [DOI] [PubMed] [Google Scholar]
  • 3.Jia Y, Huang H, Gagnier JJ. A systematic review of measurement properties of patient-reported outcome measures for use in patients with foot or ankle diseases. Qual Life Res. 2017;26:1969–2010. doi: 10.1007/s11136-017-1542-4 [DOI] [PubMed] [Google Scholar]
  • 4.Pinsker E, Daniels TR, Inrig T, Warmington K, Beaton DE. The ability of outcome questionnaires to capture patient concerns following ankle reconstruction. Foot Ankle Int. 2013;34:65–74. doi: 10.1177/1071100712460365 [DOI] [PubMed] [Google Scholar]
  • 5.Veltman ES, Hofstad CJ, Witteveen AGH. Are current foot- and ankle outcome measures appropriate for the evaluation of treatment for osteoarthritis of the ankle?: Evaluation of ceiling effects in foot- and ankle outcome measures. Foot Ankle Surg. 2017;23:168–172. doi: 10.1016/j.fas.2016.02.006 [DOI] [PubMed] [Google Scholar]
  • 6.Mani SB, Do H, Vulcano E, Hogan MV, Lyman S, Deland JT, et al. Evaluation of the foot and ankle outcome score in patients with osteoarthritis of the ankle. Bone Joint J. 2015;97-B:662–667. doi: 10.1302/0301-620X.97B5.33940 [DOI] [PubMed] [Google Scholar]
  • 7.Sieradzki JP, Larsen N, Wong I, Ferkel RD. Symptom and Disability Measurement by Common Foot and Ankle-Specific Outcome Rating Scales. Foot Ankle Int. 2020;41:849–858. doi: 10.1177/1071100720920635 [DOI] [PubMed] [Google Scholar]
  • 8.Koltsov JCB, Greenfield ST, Soukup D, Do HT, Ellis SJ. Validation of Patient-Reported Outcomes Measurement Information System Computerized Adaptive Tests Against the Foot and Ankle Outcome Score for 6 Common Foot and Ankle Pathologies. Foot Ankle Int. 2017;38:870–878. doi: 10.1177/1071100717709573 [DOI] [PubMed] [Google Scholar]
  • 9.Behrend H, Giesinger K, Giesinger JM, Kuster MS. The “forgotten joint” as the ultimate goal in joint arthroplasty: validation of a new patient-reported outcome measure. J Arthroplasty. 2012;27:430–436.e1. doi: 10.1016/j.arth.2011.06.035 [DOI] [PubMed] [Google Scholar]
  • 10.Adriani M, Malahias MA, Gu A, Kahlenberg CA, Ast MP, Sculco PK. Determining the Validity, Reliability, and Utility of the Forgotten Joint Score: A Systematic Review. J Arthroplasty. 2020;35:1137–1144. doi: 10.1016/j.arth.2019.10.058 [DOI] [PubMed] [Google Scholar]
  • 11.Furuya H, Hirohata K, Misaki S, Aizawa J, Sugimoto K. Reliability and validity of the Japanese version of the Forgotten joint score following joint replacement surgery. The Japanese Journal of Physical Therapy. 2019;53:742–750. [In Japanese] [Google Scholar]
  • 12.Ladurner A, Giesinger K, Zdravkovic V, Behrend H. The Forgotten Joint Score-12 as a valuable patient-reported outcome measure for patients after first-time patellar dislocation. Knee. 2020;27:406–413. doi: 10.1016/j.knee.2019.12.004 [DOI] [PubMed] [Google Scholar]
  • 13.Watanabe S, Akagi R, Ninomiya T, Yamashita T, Tahara M, Kimura S, et al. Comparison of joint awareness after medial unicompartmental knee arthroplasty and high tibial osteotomy: a retrospective multicenter study. Arch Orthop Trauma Surg. 2022;142:1133–1140. doi: 10.1007/s00402-021-03994-x [DOI] [PubMed] [Google Scholar]
  • 14.Stevens J, de Bot RTAL, Witlox AM, Borghans R, Smeets T, Beertema W, et al. Long-term Effects of Cheilectomy, Keller’s Arthroplasty, and Arthrodesis for Symptomatic Hallux Rigidus on Patient-Reported and Radiologic Outcome. Foot Ankle Int. 2020;41:775–783. doi: 10.1177/1071100720919681 [DOI] [PubMed] [Google Scholar]
  • 15.Niki H, Tatsunami S, Haraguchi N, Aoki T, Okuda R, Suda Y, et al. Validity and reliability of a self-administered foot evaluation questionnaire (SAFE-Q). J Orthop Sci. 2013;18:298–320. doi: 10.1007/s00776-012-0337-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–1736. doi: 10.1007/s11136-011-9903-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Maenohara Y, Taniguchi A, Tomiwa K, Tsuboyama D, Kurokawa H, Kumai T, et al. Outcomes of Bilateral vs Unilateral Ankle Arthrodesis. Foot Ankle Int. 2018;39:530–534. doi: 10.1177/1071100717749505 [DOI] [PubMed] [Google Scholar]
  • 18.Yamamoto T, Nagai K, Kanzaki N, Kataoka K, Nukuto K, Hoshino Y, et al. Comparison of Clinical Outcomes Between Ceramic-Based Total Ankle Arthroplasty with Ceramic Total Talar Prosthesis and Ceramic-Based Total Ankle Arthroplasty. Foot Ankle Int. 2022;43:529–539. doi: 10.1177/10711007211051353 [DOI] [PubMed] [Google Scholar]
  • 19.Hoogeboom TJ, de Bie RA, den Broeder AA, van den Ende CH. The Dutch Lower Extremity Functional Scale was highly reliable, valid and responsive in individuals with hip/knee osteoarthritis: a validation study. BMC Musculoskelet Disord. 2012;13:117. doi: 10.1186/1471-2474-13-117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Goyal T, Sethy SS, Paul S, Choudhury AK, Das SL. Good validity and reliability of forgotten joint score-12 in total knee arthroplasty in Hindi language for Indian population. Knee Surg Sports Traumatol Arthrosc. 2021;29:1150–1156. doi: 10.1007/s00167-020-06124-z [DOI] [PubMed] [Google Scholar]
  • 21.Rajapakshe S, Sutherland JM, Wing K, Crump T, Liu G, Penner M, et al. Health and Quality of Life Outcomes Among Patients Undergoing Surgery for End-Stage Ankle Arthritis. Foot Ankle Int. 2019;40:1129–1139. doi: 10.1177/1071100719856888 [DOI] [PubMed] [Google Scholar]
  • 22.Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42. doi: 10.1016/j.jclinepi.2006.03.012 [DOI] [PubMed] [Google Scholar]
  • 23.COSMIN checklists for assessing study qualities [Cited 2022 November 26]. In: COSMIN (COnsensus-based Standards for the selection of health Measurement IN.struments) [Internet]. https://www.cosmin.nl/tools/checklists-assessing-methodological-study-qualities/
  • 24.Behrend H, Giesinger K, Zdravkovic V, Giesinger JM. Validating the forgotten joint score-12 in patients after ACL reconstruction. Knee 2017;24:768–774. doi: 10.1016/j.knee.2017.05.007 [DOI] [PubMed] [Google Scholar]
  • 25.Robinson PG, Rankin CS, Murray IR, Maempel JF, Gaston P, Hamilton DF. The forgotten joint score-12 is a valid and responsive outcome tool for measuring success following hip arthroscopy for femoroacetabular impingement syndrome. Knee Surg Sports Traumatol Arthrosc. 2021;29:1378–1384. doi: 10.1007/s00167-020-06138-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Itoh M, Itou J, Kuwashima U, Okazaki K. Good Validity and High Internal Consistency of the Forgotten Joint Score-12 in Patients After Medial Opening Wedge High Tibial Osteotomy. J Arthroplasty. 2021;36:2691–2697. doi: 10.1016/j.arth.2021.03.028 [DOI] [PubMed] [Google Scholar]
  • 27.Shih CL, Chen SJ, Huang PJ. Clinical Outcomes of Total Ankle Arthroplasty Versus Ankle Arthrodesis for the Treatment of End-Stage Ankle Arthritis in the Last Decade: a Systematic Review and Meta-analysis. J Foot Ankle Surg. 2020;59:1032–1039. doi: 10.1053/j.jfas.2019.10.008 [DOI] [PubMed] [Google Scholar]
  • 28.Hamilton DF, Loth FL, Giesinger JM, Giesinger K, MacDonald DJ, Patton JT, et al. Validation of the English language Forgotten Joint Score-12 as an outcome measure for total hip and knee arthroplasty in a British population. Bone Joint J. 2017;99-B:218–224. doi: 10.1302/0301-620X.99B2.BJJ-2016-0606.R1 [DOI] [PubMed] [Google Scholar]
  • 29.Heijbel S, Naili JE, Hedin A, W-Dahl A, Nilsson KG, Hedström M. The Forgotten Joint Score-12 in Swedish patients undergoing knee arthroplasty: a validation study with the Knee Injury and Osteoarthritis Outcome Score (KOOS) as comparator. Acta Orthop. 2020;91:88–93. doi: 10.1080/17453674.2019.1689327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Shadid MB, Vinken NS, Marting LN, Wolterbeek N. The Dutch version of the Forgotten Joint Score: test-retesting reliability and validation. Acta Orthop Belg. 2016;82:112–118. [PubMed] [Google Scholar]
  • 31.Sansone V, Fennema P, Applefield RC, Marchina S, Ronco R, Pascale W, et al. Translation, cross-cultural adaptation, and validation of the Italian language Forgotten Joint Score-12 (FJS-12) as an outcome measure for total knee arthroplasty in an Italian population. BMC Musculoskelet Disord. 2020;21:23. doi: 10.1186/s12891-019-2985-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Robinson PG, MacDonald DJ, Macpherson GJ, Patton JT, Clement ND. Changes and thresholds in the Forgotten Joint Score after total hip arthroplasty: minimal clinically important difference, minimal important and detectable changes, and patient-acceptable symptom state. Bone Joint J. 2021;103-B:1759–1765. doi: 10.1302/0301-620X.103B12.BJJ-2021-0384.R1 [DOI] [PubMed] [Google Scholar]
  • 33.Bramming IB, Kierkegaard S, Lund B, Jakobsen SS, Mechlenburg I. High relative reliability and responsiveness of the forgotten joint score-12 in patients with femoroacetabular impingement undergoing hip arthroscopic treatment. A prospective survey-based study. J Hip Preserv Surg. 2019;6:149–156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Roos EM, Brandsson S, Karlsson J. Validation of the foot and ankle outcome score for ankle ligament reconstruction. Foot Ankle Int. 2001;22:788–794. doi: 10.1177/107110070102201004 [DOI] [PubMed] [Google Scholar]
  • 35.Richter M, Agren PH, Besse JL, Cöster M, Kofoed H, Maffulli N, et al. EFAS Score—Multilingual development and validation of a patient-reported outcome measure (PROM) by the score committee of the European Foot and Ankle Society (EFAS). Foot Ankle Surg. 2018;24:185–204. doi: 10.1016/j.fas.2018.05.004 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Fatih Özden

24 Mar 2023

PONE-D-23-04534Reliability and validity of the Forgotten Joint Score-12 for total ankle replacement and ankle arthrodesisPLOS ONE

Dear Dr. Yamaguchi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 08 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Fatih Özden, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Additional Editor Comments:

Please find the reviewer reports below. Kind Regards

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

this is an interesting study and should have been conducted earlier, this will help the F&A society to improve outcome measurements. I have the following comments:

- English could be shortened

- Spelling mistakes on page 12 line 201 and 202

-Why did you not statistic testing on patients groups (Tbl1)

These are minor issues and the excellent study is worth publishing in my view.

Best regards

Reviewer #2: The manuscript aimed to examine the reliability and validity of the Japanese Forgotten Joint Score-12 (FJS-12) in patients with total ankle replacement (TAR) and ankle arthrodesis (AA). The manuscript is interesting, well-written, and presented in an organized fashion. I have only one comment on the work as presented below:

1- Abstract, please report the SEM and MDC in the Results section. As well, the Conclusion should consider that the Japanese version has been evaluated for metric characteristics and found reliable and valid.

2- Please use appropriate statistical test to compare the two groups of TAR and AA on the FJS-12 scores. The result may indicate the discriminant ability of the questionnaire.

Reviewer #3: The authors have provided a purposeful and unique study. A comprhensive English editing is required to shorten the length of the sentences and also grammatical issues should be handled to improve the comprehensibility of the paper. Alsa, formula based sample size calculation is required.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Noureddin Nakhostin Ansari

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Fatih Özden

24 Apr 2023

PONE-D-23-04534R1Reliability and validity of the Forgotten Joint Score-12 for total ankle replacement and ankle arthrodesisPLOS ONE

Dear Dr. Yamaguchi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Additional Editor Comments:

Dear Authors,

Please find one of the reviewers' comments, both major and minor issues raised. I look forward your corrected paper soon.

Best Regards

Please submit your revised manuscript by Jun 08 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Fatih Özden, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I appreciate the efforts of the authors in revising the manuscript. The manuscript looks better, but there are still issues that is required to be addressed.

Abstract

1- Results, please report the results on know-group validity.

2- Conclusions, lines 55-57 are repetitions with results. I would suggest omitting them.

Introduction

1- Page 6, line 87, "I would suggest omitting "effectiveness" and inserting "usefulness", please.

Metods

1- Page 10, line 171, please clarify the statement on the confirmation of 75% of hypotheses for construct validity in the context of your study.

2- Page 10, line 172, please analyze the exploratory factor analysis considering all the data on Japanese FJS-12 from both groups (n==115) .

3- Page 10, line 177, on ICC, Please clarify, Single measure or average measure? Further, absolute or consistency? ICC agreement was used? Please also provide reason/reasons for using the two-way mixed-effects model.

4- Page 11, line 191, how 63 patients were calculatedfor sample size? Terwee et al (2007) suggest at least 100 patients. This needs clarification.

Results

1- Page 12, Table 1, last coloumn, please report the tests used along with p values.

2- Page 17, lines 253-259, you were needed to analyze the floor and ceiling effects for FJS-12 scores. You may omit reports findings on the floor and ceiling effects for SAFE-Q scores and EQ-5D-5L. Please clarify it.

Discussion

1- This section should also focus on the examination of the Japanese FJS-12 scores known-group validity that was not confirmed. Findings on the factor analysis should also considered for the revised paper.

2- Page 20, Conclusions, please avoid repetitions of the results and focus instead on the outcomes of the study, and whether you were successful in addressing the gaps as already stated in the Introduction.

Reviewer #3: Thanks for your revision. The manuscript is now suitable for publication regarding my point of view.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Noureddin Nakhostin Ansari

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Fatih Özden

23 May 2023

Reliability and validity of the Forgotten Joint Score-12 for total ankle replacement and ankle arthrodesis

PONE-D-23-04534R2

Dear Dr. Yamaguchi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Fatih Özden, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Fatih Özden

5 Jun 2023

PONE-D-23-04534R2

Reliability and validity of the Forgotten Joint Score-12 for total ankle replacement and ankle arthrodesis

Dear Dr. Yamaguchi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Fatih Özden

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Japanese version of FJS-12.

    (DOCX)

    S2 File. FJS scores.

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES